|
|
|
| Therapeutic Effect of Meglumine Adenosine Cyclophosphat Combined with Musk Baoxin Pill on the Treatment of Chronic Pulmonary Heart Disease with Heart Failure |
| LIU Xue-jiao |
| Beijing Daxing Distrtict People's Hospital, Beijing 102600 |
|
|
|
|
Abstract 【Objective】To observe the efficacy of meglumine adenosine cyclophosphat combined with musk Baoxin pill on the treatment of chronic pulmonary heart disease with heart failure. 【Methods】A total of 110 patients with chronic pulmonary heart disease and heart failure were enrolled. According to the random number table method, the patients were divided into the observation group (55 cases, with treatment of meglumine adenosine cyclophosphat combined with musk Baoxin pill) and the control group (55 cases, with meglumine adenosine cyclophosphat treatment only). Lung function indexes (FEV1, FEV1/FVC), blood gas analysis indexes (SaO2, PaO2), cardiac function indicators (LVEF, LVD, CO, LVS) before and after treatment were analyzed. The efficacy, occurrence of adverse drug reactions, and the mortality within 14 days were observed. 【Results】The total effective rate of the observation group at the end of treatment was 96.36%, which was higher than that of the control group (83.64%), the difference was statistically significant (χ2=4.946,P=0.026). After treatment, the parameters of SaO2, PaO2, FEV1 and FEV1/FVC in the two groups were higher than those before treatment. Of which, the SaO2, PaO2 in the control group were higher than those in the observation group; and the difference was statistically significant (P<0.05). However, there were no significant differences in FEV1 and FEV1/FVC between the two groups after treatment (P>0.05). The LVEF of the control group after the treatment was higher than that before treatment, while both LVD and LVS of the observation group were lower than those of the control group, the differences were statistically significant (P<0.05). There was no significant difference in the incidence of adverse reactions and mortality rate between the control group and the observation group (P>0.05). 【Conclusion】Meglumine adenosine cyclophosphat combined with musk Baoxin pill has good clinical effect on the treatment of chronic pulmonary heart disease with heart failure, which improves the cardiac function and blood gas analysis indicators and reduces pulmonary artery pressure safely.
|
|
Received: 15 May 2019
|
|
|
|
|
|
[1] Roberts WC, Shafii AE, Grayburn PA, et al. Clinical and morphologic features of acute, subacute and chronic cor pulmonale (pulmonary heart disease)[J].Am J Cardiol,2015,115(5):697-703.
[2] 孙向阳.环磷腺苷葡胺联合咪达普利治疗慢性心力衰竭的临床疗效[J].实用心脑肺血管病杂志,2018,26(11):97-99.
[3] 赵雪林.盐酸川芎嗪注射液治疗慢性肺源性心脏病合并心力衰竭的临床疗效观察[J].医学临床研究,2013,30(6):1164-1165.
[4] 肖俊生.老年慢性肺源性心脏病心力衰竭的相关因素分析及临床诊治[J].临床肺科杂志,2014,19(3):518-520.
[5] 周海蓉,段学燕,赵力敏, 等.托拉塞米联合环磷腺苷葡胺治疗老年慢性心功能不全的应用价值[J].中国老年学杂志,2018,38(18):4374-4376.
[6] 刘红梅.冠心病稳定型心绞痛患者口服麝香保心丸的疗效及安全性分析[J].心血管康复医学杂志,2018,27(6):684-687.
[7] 赵洁慧,左君丽.麝香保心丸治疗冠心病合并高血压获益探讨[J].中西医结合心脑血管病杂志,2018,16(16):2329-2330.
[8] Ferrari R, Bohm M, Cleland JG, et al. Heart failure with preserved ejection fraction: uncertainties and dilemmas[J].Eur J Heart Fail,2015,17(7):665-671. |
|
|
|
2020, Vol. 37 
